These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9923961)

  • 21. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time trends in breast cancer screening rates in the OECD countries.
    Saika K; Sobue T
    Jpn J Clin Oncol; 2011 Apr; 41(4):591-2. PubMed ID: 21447696
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosing breast cancer at earlier stages of disease.
    Fulton JP; Donahue FA; Browning C
    R I Med; 1994 Oct; 77(10):362. PubMed ID: 7803870
    [No Abstract]   [Full Text] [Related]  

  • 25. Concerning the National Breast and Cervical Cancer Early Detection Program.
    Kopans DB
    AJR Am J Roentgenol; 1998 Jul; 171(1):269. PubMed ID: 9648811
    [No Abstract]   [Full Text] [Related]  

  • 26. A question that will not go away: at what age should mammographic screening begin?
    Forrest AP; Alexander FE
    J Natl Cancer Inst; 1995 Aug; 87(16):1195-7. PubMed ID: 7563158
    [No Abstract]   [Full Text] [Related]  

  • 27. Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.
    Feuer EJ
    J Natl Cancer Inst Monogr; 2006; (36):2-6. PubMed ID: 17032887
    [No Abstract]   [Full Text] [Related]  

  • 28. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast cancer: what patients for selective screening?].
    Nau JY
    Rev Med Suisse; 2014 Jun; 10(433):1266-7. PubMed ID: 25004775
    [No Abstract]   [Full Text] [Related]  

  • 30. Study design and statistics in the epidemiology of breast cancer.
    Maraqa L; Lansdown M
    Br J Cancer; 2006 Nov; 95(9):1301; author reply 1302-3. PubMed ID: 17024126
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlations between malignant breast cancer and breast screening in Hungary, based on the National Health Insurance Fund database].
    Gresz M
    Orv Hetil; 2012 Nov; 153(44):1745-51. PubMed ID: 23103744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related accuracy of screening mammography: how should it be measured?
    Feig SA
    Radiology; 2000 Mar; 214(3):633-40. PubMed ID: 10715022
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening mammography re-evaluated.
    Miller AB; Baines CJ; To T; Wall C
    Lancet; 2000 Feb; 355(9205):747; author reply 752. PubMed ID: 10703818
    [No Abstract]   [Full Text] [Related]  

  • 34. Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams.
    Blanks RG; Moss SM; Wallis MG
    J Med Screen; 2001; 8(1):24-8. PubMed ID: 11373846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Early results of breast cancer screening research].
    Nowicki A; Stogowska I
    Ginekol Pol; 2007 Jun; 78(6):464-70. PubMed ID: 17899703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New screening techniques for breast cancer (MRI).
    Gilbert FJ
    Dis Markers; 1999 Oct; 15(1-3):115-6. PubMed ID: 10595263
    [No Abstract]   [Full Text] [Related]  

  • 37. Controversy over mammography screening.
    Reidy J; Hoskins O
    BMJ; 1988 Oct; 297(6654):932-3. PubMed ID: 3142556
    [No Abstract]   [Full Text] [Related]  

  • 38. Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Maehlen J
    Dan Med Bull; 2006 Nov; 53(4):438-40. PubMed ID: 17150148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer screening in the Flemish region, Belgium.
    Van Oyen H; Verellen W
    Eur J Cancer Prev; 1994 Jan; 3 Suppl 1():7-12. PubMed ID: 8130728
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.